Octagon Capital Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-695,000	Closed	-$12.7M	–	34
2023 Q3	$12.7M	Buy	+695,000	New	+$12.7M	1.96%	14